Abstract
BackgroundMethotrexate (MTX) is the anchor drug used in the treatment of juvenile idiopathic arthritis (JIA). Leflunomide (LFD) has comparable efficacy to MTX in adults with rheumatoid arthritis, and there is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
